slot.vip app
slot.vip app
My Special Aflac Duck® lands in the Sacramento ValleySitting down for most of the day is obviously bad for us, known to raise our risk of type 2 diabetes, cancer and even an early death. However, it’s largely unavoidable for those of us with desk-based jobs. Too much sitting is also detrimental for our mental health, a study from sportswear company Asics has found. Survey results from more than 7000 desk-based workers found that mood drops after just two hours and stress spikes four hours in. However, taking a 15-minute exercise break reverses these effects. Taking a midday stroll or jog can vastly improve your health at work. Credit: Joe Armao Professor Brendon Stubbs, a researcher in movement and mental wellbeing at King’s College London, who led the study, says incorporating movement into our working day – among other healthy habits – could be game-changing. “Each habit can contribute to positive mental health, and the more people do, especially over time, the greater the physical and mental health benefits,” he says. Here, he shares his top tips. 8am: Read a book on your commute instead of scrolling social media. Most of us are spending up to nine hours of our day sitting down. If you’re seated for your commute, at least make sure you’re engaging your brain, Stubbs says. “It is passive sedentary behaviour (such as sitting down to watch Netflix or scroll social media) and not active sedentary behaviour (sitting down to read a book or play a game, for example) that is particularly not good for our mental health,” he explains. Swap your afternoon biscuit for a bar of dark chocolate, a healthier option that can lift your mood. A study from Stubbs and colleagues which looked at the self-reported health habits and medical notes of around 40,000 people found that those engaging in more than three hours of active sedentary behaviour per day had a 26 per cent lower risk of depression compared to those who did less than this. “Additionally, our research has shown that excessive social media is literally rewiring our brain and altering our reward-processing systems, making it harder to become motivated for everyday tasks,” Stubbs adds. 11am: Breathing exercises to reduce stress spike. The Asics research found that it is after just two hours into desk-based work that stress levels start to rise – so around 11am if your working day starts at 9am. “To combat this, do some deep nasal breathing in the morning,” Stubbs recommends. Research from Stanford University found that just five minutes of breathing exercises can reduce anxiety, improve mood and slow breathing, which is a sign that the body is calm. To try it, sit up in your seat and relax your shoulders. Inhale slowly through your nose, letting your belly rise and fill with air. Once your lungs are comfortably full, take another inhale of air to expand your lungs as much as possible. Then, exhale slowly through your mouth, making sure that it lasts longer than your inhale. Repeat for five to 10 minutes. “This can help calm the nervous system and set our body and minds on a good foundation to be clear of mind and calm for the day,” Stubbs adds. 12pm: Eat a homemade lunch. More than half of the calories we eat each day comes from ultra-processed foods (those containing ingredients you wouldn’t find in your kitchen cupboard, such as preservatives, emulsifiers and artificial flavourings). A diet high in these foods is linked to a 30 per cent higher risk of depression in the future, and there are also links to obesity, type 2 diabetes, heart problems and even some cancers. A homemade lunch is a better option than processed store-bought food. Credit: iStock A homemade lunch that avoids ultra-processed ingredients and instead incorporates elements of the Mediterranean diet (vegetables, fruit, wholegrains, fish and olive oil) can help protect against these risks and improve mood, Stubbs says. “Make something that includes a good amount of whole grains, such as wholewheat bread and brown rice, fish – especially those rich in omega-3 fatty acids – or lentils and pulses, which are a good source of protein,” he says. For example, this could be a tuna sandwich made with wholemeal bread, a chickpea curry with brown rice, or a lentil and vegetable soup. 2pm: Move for 15 minutes. It’s around halfway through our working day that stress levels spike – sitting around a fifth higher than they were at the start of the day – the Asics study found. However, taking a 15-minute exercise break reversed this effect. “Our recent research has shown that moving for 15 minutes, especially after sitting for a prolonged period of time, can reduce stress by 14.7 per cent and improve your state of mind,” Stubbs says. This could be a walk, which would add around 1500 steps to your daily count, weightlifting or a short HIIT (high-intensity interval training) class. The positive effect of movement is thought to be down to it triggering the brain to release mood-boosting neurotransmitters, including endorphins, dopamine and serotonin, Stubbs explains. 3pm: Eat a piece of dark chocolate. Swap your afternoon biscuit for a bar of dark chocolate, a healthier option that can lift your mood, Stubbs suggests. Dark chocolate is full of antioxidants and fibre and has been linked to lower blood pressure, healthier cholesterol levels and brain function. The afternoon is the ideal time for this snack, as it contains caffeine, which may disrupt sleep for some people if it is eaten in the evening, he notes. Research from Stubbs and colleagues, which examined the daily chocolate consumption and mood of around 13,000 people, found that those who ate dark chocolate – around 100g per day – were around 57 per cent less likely to develop depression symptoms than those who didn’t eat chocolate. However, bear in mind that 100g of dark chocolate will contain around 600 calories and 14g of sugar, so a smaller portion may be best. A single 10g square has still been linked to health benefits. 6pm: Avoid alcohol and go for a soft drink after work. Despite its initial relaxing effects, alcohol isn’t good for us. It harms our heart and brain and raises the likelihood that we will suffer from high blood pressure, stroke and cancer. In Britain we’re told to not exceed 14 units per week (around six 175ml glasses of wine, six pints of 4 per cent beer or 14 single shots of spirit). However, “the research suggests that no level of alcohol consumption is associated with better health,” Stubbs notes. So when it comes to after-work drinking, try to avoid it, he recommends. “Swap to a hydrating drink,” he suggests. “Try kombucha [a fizzy drink made from fermented black tea] or an alcohol-free option of your favourite drink.” - Telegraph The Business Briefing newsletter delivers major stories, exclusive coverage and expert opinion. Sign up to get it every weekday morning .Synopsys, Inc. (NASDAQ:SNPS) Shares Purchased by PNC Financial Services Group Inc.
STEVE FLOWERS: Alabama is one big front porchA look at how some of Trump's picks to lead health agencies could help carry out Kennedy's overhaul
NonePriyanka Gandhi wins Wayanad LS seat with margin of over 4.1 lakh votes
Keratoconus Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, Clinical Trials by DelveInsight | CooperVision, Optik Seis, SAFILENS S.R.L, Novartis, CIBA VISION, Menicon, Bausch & Lomb 11-25-2024 08:31 PM CET | Health & Medicine Press release from: DelveIinsight Business Research (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Keratoconus pipeline constitutes 3+ key companies continuously working towards developing 3+ Keratoconus treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Keratoconus Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Keratoconus Market. The Keratoconus Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details. Some of the key takeaways from the Keratoconus Pipeline Report: https://www.delveinsight.com/sample-request/keratoconus-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr •Companies across the globe are diligently working toward developing novel Keratoconus treatment therapies with a considerable amount of success over the years. •Keratoconus companies working in the treatment market are Glaukos Corporation, iVeena Delivery Systems, Ocular Therapeutix, Inc., and others, are developing therapies for the Keratoconus treatment •Emerging Keratoconus therapies in the different phases of clinical trials are- Riboflavin 5'-Phosphate, IVMED-80, Dextenza, and others are expected to have a significant impact on the Keratoconus market in the coming years. •In October 2024, Glaukos Corporation (NYSE: GKOS), a pharmaceutical and medical technology company specializing in innovative treatments for glaucoma, corneal disorders, and retinal diseases, announced positive results from the second Phase 3 confirmatory pivotal trial for EpioxaTM (Epi-on). This next-generation corneal cross-linking iLink therapy for keratoconus met its pre-specified primary efficacy endpoint, showing a clinically meaningful and statistically significant improvement in maximum corneal curvature (Kmax) at 12 months compared to the sham/placebo-controlled group. Kmax, an FDA-accepted primary efficacy metric for keratoconus trials, measures the steepest corneal curvature using topography, with higher Kmax values indicating corneal steepening and disease progression. Keratoconus Overview Keratoconus is a progressive eye disease in which the normally round, dome-shaped cornea thins and begins to bulge into a cone-like shape. This cone shape deflects light as it enters the eye, causing distorted vision. Get a Free Sample PDF Report to know more about Keratoconus Pipeline Therapeutic Assessment- https://www.delveinsight.com/report-store/keratoconus-pipeline-insight Emerging Keratoconus Drugs Under Different Phases of Clinical Development Include: •Riboflavin 5'-Phosphate: Glaukos Corporation •IVMED-80: iVeena Delivery Systems •Dextenza: Ocular Therapeutix, Inc. Keratoconus Route of Administration Keratoconus pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as •Oral •Parenteral •Intravenous •Subcutaneous •Topical Keratoconus Molecule Type Keratoconus Products have been categorized under various Molecule types, such as •Monoclonal Antibody •Peptides •Polymer •Small molecule •Gene therapy Keratoconus Pipeline Therapeutics Assessment •Keratoconus Assessment by Product Type •Keratoconus By Stage and Product Type •Keratoconus Assessment by Route of Administration •Keratoconus By Stage and Route of Administration •Keratoconus Assessment by Molecule Type •Keratoconus by Stage and Molecule Type DelveInsight's Keratoconus Report covers around 3v+ products under different phases of clinical development like •Late-stage products (Phase III) •Mid-stage products (Phase II) •Early-stage product (Phase I) •Pre-clinical and Discovery stage candidates •Discontinued & Inactive candidates •Route of Administration Further Keratoconus product details are provided in the report. Download the Keratoconus pipeline report to learn more about the emerging Keratoconus therapies https://www.delveinsight.com/sample-request/keratoconus-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key companies in the Keratoconus Therapeutics Market include: Key companies developing therapies for Keratoconus are - CooperVision, Optik Seis, SAFILENS S.R.L, Novartis AG, CIBA VISION, Menicon Co. Ltd, Bausch & Lomb Incorporated, Johnson & Johnson Vision Care Inc, HOYA Vision Care, and others. Keratoconus Pipeline Analysis: The Keratoconus pipeline report provides insights into •The report provides detailed insights about companies that are developing therapies for the treatment of Keratoconus with aggregate therapies developed by each company for the same. •It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Keratoconus Treatment. •Keratoconus key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects. •Keratoconus Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. •Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Keratoconus market. The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc. Download Sample PDF Report to know more about Keratoconus drugs and therapies https://www.delveinsight.com/sample-request/keratoconus-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Keratoconus Pipeline Market Strengths •Environmental factors contribute to the wide variation in prevalence. Geographical locations with plenty of sunshine and hot weather have a higher prevalence than locations with colder climates and less sunlight Keratoconus Pipeline Market Opportunities •There is limited approved therapy for Keratoconus, which opens up a huge platform of new therapies to boon the market. Scope of Keratoconus Pipeline Drug Insight •Coverage: Global •Key Keratoconus Companies: Glaukos Corporation, iVeena Delivery Systems, Ocular Therapeutix, Inc., and others •Key Keratoconus Therapies: Riboflavin 5'-Phosphate, IVMED-80, Dextenza, and others •Keratoconus Therapeutic Assessment: Keratoconus current marketed and Keratoconus emerging therapies •Keratoconus Market Dynamics: Keratoconus market drivers and Keratoconus market barriers Request for Sample PDF Report for Keratoconus Pipeline Assessment and clinical trials https://www.delveinsight.com/sample-request/keratoconus-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Table of Contents 1. Keratoconus Report Introduction 2. Keratoconus Executive Summary 3. Keratoconus Overview 4. Keratoconus- Analytical Perspective In-depth Commercial Assessment 5. Keratoconus Pipeline Therapeutics 6. Keratoconus Late Stage Products (Phase II/III) 7. Keratoconus Mid Stage Products (Phase II) 8. Keratoconus Early Stage Products (Phase I) 9. Keratoconus Preclinical Stage Products 10. Keratoconus Therapeutics Assessment 11. Keratoconus Inactive Products 12. Company-University Collaborations (Licensing/Partnering) Analysis 13. Keratoconus Key Companies 14. Keratoconus Key Products 15. Keratoconus Unmet Needs 16 . Keratoconus Market Drivers and Barriers 17. Keratoconus Future Perspectives and Conclusion 18. Keratoconus Analyst Views 19. Appendix 20. About DelveInsight Related Reports: Keratoconus Market https://www.delveinsight.com/report-store/keratoconus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr DelveInsight's 'Keratoconus Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), Keratoconus Epidemiology https://www.delveinsight.com/report-store/keratoconus-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr DelveInsight's 'Keratoconus Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Latest Reports Offered By DelveInsight: •Structural Heart Devices Market: https://www.delveinsight.com/report-store/structural-heart-devices-market-market •Prosthetic Heart Valve Market: https://www.delveinsight.com/report-store/prosthetic-heart-valve-market •Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market •Cardiac Arrythmia Market: https://www.delveinsight.com/report-store/ambulatory-arrhythmia-monitoring-devices-market •Alopecia Market: https://www.delveinsight.com/report-store/alopecia-areata-market •Optical Coherence Tomography Devices Market: https://www.delveinsight.com/report-store/optical-coherence-tomography-oct-devices-market Contact Us: Gaurav Bora gbora@delveinsight.com +14699457679 Healthcare Consulting https://www.delveinsight.com/consulting-services About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach. This release was published on openPR.President Bola Tinubu’s frequent trips outside the country, which are reportedly about 30, has attracted comments from many Nigerians, who view the constant trips as jamboree and waste of resources at a period the nation is experiencing serious crisis occasioned by fuel subsidy removal and floating of the naira by the current administration. It will be recalled that the president started his official travels in June 2023, a few weeks after he took the oath of office. His media team was quoted to have said that the purpose of the numerous travels was to strengthen Nigeria’s position on the global stage, foster economic growth, and address some of the country’s other challenges. However, data from GovSpend, a BudgIT Foundation analytics platform, revealed that between February 21 and July 19, Tinubu spent N2, 346,623,000 on foreign trips. Since then the expenditures incurred on foreign trips have increased because the President had embarked on several trips since July. Critics have, however, raised the alarm that the frequent foreign travels by the President have not yielded commensurable results to benefit Nigerians at a time they are facing excruciating pains owing to the policies of the government. They hold that the humongous amount of money expended on the foreign trips could have been better spent in fixing the nation’s infrastructures. Critics’ positions Comrade Emeka Nkwoala, Delta State chairman of Zenith Labour Party (ZLP), has said that the trips are just a jamboree. He believes that Nigeria only needs a home grown solution to her myriad of challenges, saying that President Tinubu should sit at home and face these issues squarely. He said: “This travels are just jamborees. That’s not what is needed. We need a home grown solution to our myriads of challenges. Our President should sit at home and face these issues squarely. Nigeria ought to benefit from foreign direct investment (FDI) but that is not happening because the local investors in the country are not smiling. They consult them (intended investors), and their stories are not funny. “They face challenges of insecurity, high and multiple taxation; high and unreliable energy cost, volatility of the foreign exchange, inconsistent government policies and lack of government patronage, the list goes on. “President Bola Ahmed Tinubu must stop these travels and take up the task of nation’s building vigorously. He should also end hunger and hardship in the land, especially since the sudden removal of fuel subsidies.” Also, Chief Nkereuwem Udofia Akpan, a human rights activist and constitutional lawyer, says though there’s a Constitutional limit as to how long the President can be away from office without handing over to the Vice President, there’s no limit as to how many trips he can make abroad within a particular time frame. “But here is the deal, incessant travels fuels the rumour mills that he is unwell. Unless his handlers find a plausible explanation for the prolonged trips, then we are in for a constitutional crisis sooner or later,” Akpan said. A don at the University of Lagos, Professor Christopher Anyokwu, in his reaction, said: “Like every right-thinking Nigerian, I know his travels are not likely to do much by way of attracting FDI, inter alia. “Frankly, the less said the better. I’m utterly disappointed in this government as things stand.” His counterpart at the Delta State University, Abraka, Dr Boniface Chukwuma Anyanwu (Associate Professor), has also said that it’s only right that he travels for the benefit of justifying the CIA and its interest. He added: “But, what can possibly be relevant and beneficial from the travels that we’re not seeing from the beginning? About 30 times in about 30 months in office, and no sign of anything positive; why would Nigerians expect anything? “Can anything good come out of Nazareth? That question came from the Holy Book. Something more than good eventually came from Nazareth, you know. “But again, with the American CIA declaring the traveller as an asset or what was the word again, it’s only right that he travels for the benefit of justifying the CIA and its interest.” Presidency reacts But the Presidency has consistently maintained that the President needed to move around the world in search of foreign direct Investments (FDI) and to re-establish the nation as the premium economic powerhouse in Africa. In his response to the many criticisms against Tinubu’s frequent travels, the Special Adviser to the President on Media and Public Communication, Mr Sunday Dare, said: “Such criticisms are misplaced and unfair. “Part of the job of a President is to travel to important global meetings to interact with other leaders at bilateral and multilateral levels. The President is the diplomat-in-chief and marketer-in-chief of the country. He represents Nigeria and Nigeria must never be missing at the table. “The president’s foreign trips have brought important benefits to the country. The Prime Minister just visited last Sunday on his way to the G20 Summit in Rio. “The last time an Indian PM visited Nigeria was 2007. India is now the 4th largest economy in the world and one of the top trading partners of our country. “The Indian PM invited President Tinubu to the G20 Summit last year and the government attracted $14bn dollars investment from Indian businessmen.” He added: “Some of these investments are in Nigeria and at the meeting in Nigeria on Sunday; the PM further assured the remaining commitments will soon be implemented. “On this current trip to the G20 Summit in Brazil, the Ministry of Agriculture signed on behalf of the Federal Government $1.2bn deal on food security that will advance private sector development in fertiliser production, hybrid seed technology and agric financing. “The deal is between the Federal Government and the Brazilian government. The job of a President is not only to stay in the office. A president must go out to market his country, to promote investment climate, people to people diplomacy and generate goodwill abroad. “These things can only happen when he embarks on these diplomatic shuttles. They are very important and essential for national development and progress. “President Tinubu gets invited for State Visits and Official Visits by world leaders because of Nigeria’s preeminent role in Africa and world affairs.”
CIBC Asset Management Inc Purchases New Holdings in Pinnacle Financial Partners, Inc. (NASDAQ:PNFP)IOWA CITY — Iowa named Jackson Stratton its starting quarterback for the regular season finale against Nebraska on Black Friday. Stratton picked up a win over Maryland in his first career start on Saturday, filling in for an injured Cade McNamara and Brendan Sullivan at quarterback. Iowa quarterback Jackson Stratton warms up before an NCAA college football game against Wisconsin, Saturday, Nov. 2, 2024, in Iowa City, Iowa. Iowa head coach Kirk Ferentz praised Stratton, who finished the win over the Terrapins with 76 yards on 10-of-14 passing and a 117 passing efficiency rating, during a postgame interview with the Hawkeye Radio Network. “He really, I thought, played with great poise,” Ferentz said. “Also, awareness, for a guy who has never started a game ... it did not seem to affect him at all. He really did a good job of preparing himself and did a really nice job of inserting himself. I thought he really played a good game.” With Stratton in line for his second career start, Marco Lainez III, who started the season as Iowa's third string quarterback, will serve as Stratton's backup on Friday. Lainez suffered a thumb injury on his non-throwing hand last month before returning to practice last week. McNamara, who topped Iowa's depth chart last Monday, but was not cleared to return to game action, did not appear on the two deep. McNamara released a statement via social media which dispelled rumors of his departure from the Iowa football program. "It has come to my attention that there are individuals in the media circulating rumors about my current status on the Iowa Football Team," McNamara wrote. "These are ridiculous accusations and 100% false. My status on the same as it's always been — a proud member of this football team. "I have every intention to play versus Nebraska next Friday night." In addition to McNamara, cornerback Jermari Harris, who was the subject of reports from 247Sports indicating he opted out of the final two games of the season in preparation for the NFL Draft, also did not appear on the depth chart. On Friday, Ferentz released a statement that said Harris would not play against Maryland due to a "medical issue." "We hope all our student-athletes can play next week in our regular season finale at Kinnick Stadium, however, a player's health and wellbeing are always our top priority," Ferentz said in the statement. "There are several players who will not compete in Saturday's game against Maryland because they have not been cleared medically (or by the medical team). "The decision of whether a student-athlete can compete after sustaining an injury is made by the medical team." Harris proved to be a reliable shutdown corner on the left side of the Hawkeyes' defense in his 10 appearances this season. The senior from Chicago recorded 27 total tackles (19 solo), 10 passes defended, three interceptions, including a pick six, and one tackle for loss. Pro Football Focus graded Harris as the No. 9 overall cornerback in the FBS this season. Nick DeJong will also start at right tackle in place of an injured Gennings Dunker. Iowa (7-4, 5-3 Big Ten) will face Nebraska (6-5, 3-5 Big Ten) at 6:30 on Friday with broadcast coverage provided by NBC. After Iowa's win over Maryland, uncertain reigns at quarterback and questions swirl regarding what version of Nebraska the Hawkeyes will face and what the stakes are on Black Friday. A career-long kick, an early stop and two-way one-two punch help Iowa secure its second road win of the season at Maryland on Saturday. Iowa outgained and out-possessed Maryland while limiting the Terrapins explosive passing attack to a season-low performance to earn its seventh win of the season on Sautrday. Iowa learned from its 2023 mistakes, leaned on the ground game, defense and Drew Stevens's turnaround to beat Maryland in its road finale on Saturday. Get local news delivered to your inbox! University of Iowa Athletics Beat Reporter {{description}} Email notifications are only sent once a day, and only if there are new matching items.
Andy Murray enters new chapter with Novak Djokovic as coach of long-time rivalSpecific laws needed to combat cyber harassment
UCF will attempt to shake off a dreadful offensive performance when it collides with LSU on Sunday afternoon in the third-place game of the Greenbrier Tip-Off in White Sulphur Springs, W.Va. The Knights (4-1) couldn't get anything going against No. 19 Wisconsin on Friday, going 21-for-62 from the field (33.9 percent) and just 2-for-17 from 3-point range (11.8 percent) en route to an 86-70 loss. Jordan Ivy-Curry finished with 13 points while Keyshawn Hall and Dior Johnson added 11 apiece for UCF, which never led and fell behind by as many as 23. Knights coach Johnny Dawkins is hoping that his team's struggles don't carry over into the meeting with the Tigers (4-1). "We have to do better offensively," Dawkins said. "We have to space the floor better. We have to balance our offense between our perimeter and our bigs. Those are things that we didn't do consistently (on Friday)." LSU also needs to clean things up after committing 15 turnovers in a 74-63 setback against Pitt on Friday. Tigers forward Jalen Reed doesn't believe giving the ball away will be a lingering issue. "I feel like a lot of our turnovers were more on us than them," Reed said. "I feel like a lot of the turnovers were careless, but we're a better team than that and I feel like we'll take care of the ball better moving forward." Reed and Vyctorius Miller each posted 14 points in the loss to the Panthers, with Reed also hauling in seven rebounds. Cam Carter chipped in 11 points. Carter is putting up a team-leading 16.4 points per game. Jordan Sears (12.0 points per game), Reed (11.0) and Miller (10.2) also have scoring averages in double figures. Ivy-Curry (16.8 points per game), Hall (16.2) and Darius Johnson (13.0) have been leading the way for UCF. Sunday marks the first-ever meeting between the Knights and Tigers. --Field Level MediaTim Cook won't leave Apple 'til a voice in his head tells him to do so
TEXAS: Dr. Aafia Siddiqui, the Pakistani neuroscientist, who studied at institutions including Brandeis University and the Massachusetts Institute of Technology and is serving an 86-year sentence at the Federal Medical Center (FMC) Carswell in Fort Worth, Texas, has filed a federal lawsuit accusing US prison officials of severe human rights abuses. The 61-page complaint, lodged in the US District Court for the Northern District of Texas, claims Siddiqui has faced ongoing sexual assault, physical abuse, denial of medical care, and religious discrimination during her imprisonment since 2010. The lawsuit names the US government, the Federal Bureau of Prisons (BOP), and several prison officials, detailing numerous incidents of mistreatment. Siddiqui alleges that prison guards, including male officers, subjected her to repeated sexual assault under the guise of routine searches. She further accuses prison staff of retaliating against her for reporting the abuse, including an incident in which she was allegedly doused with a burning acidic substance. A significant portion of the lawsuit highlights violations of Siddiqui’s religious rights. Despite being a devout Muslim, Siddiqui has been denied access to an Imam for spiritual guidance, and her requests for religious items and participation in Friday prayers have been repeatedly blocked. The lawsuit details how male officers have observed her during private moments, including when she was forced to strip, further infringing upon her religious freedoms. Additionally, the complaint addresses the lack of adequate medical care, noting that Siddiqui has suffered from physical ailments, including hearing loss and dental issues, as a result of prior alleged torture in US custody. Her attorneys argue that the failure to provide proper care for Siddiqui’s documented PTSD and physical injuries violates her constitutional rights under the Eighth Amendment, which prohibits cruel and unusual punishment. The case is framed within a broader context of systemic issues at FMC Carswell, where previous reports and lawsuits have pointed to widespread abuse of female inmates. A 2022 investigation by the Fort Worth Star-Telegram revealed numerous cases of sexual misconduct by prison staff, many of which were either covered up or inadequately addressed. Dr. Siddiqui’s legal team, which includes attorneys Naim Haroon Sakhia, Maria Kari, and Clive Stafford Smith, is seeking a jury trial and demanding an independent investigation into the allegations. Earlier in 2022, in a lawsuit against the federal Bureau of Prisons, Siddiqui’s lawyers had said that another inmate had “smashed a coffee mug filled with scaling hot liquid” into her face. When Siddiqui curled herself into a fetal position, the other woman began to punch and kick her, leaving her with injuries so severe that she needed to be taken by wheelchair to the prison’s medical unit.. Siddiqui was left with burns around her eyes and a three-inch scar near her left eye, the lawsuit says. She also suffered bruises on her arms and legs and an injury to her cheek. They have been calling for immediate action to protect Siddiqui from further harm, improve her access to religious counsel, and ensure she receives adequate medical care. The case has drawn significant international attention, with human rights activists and supporters calling for justice for Siddiqui and other female inmates subjected to similar abuse. The Pakistani government has also repeatedly called for her release and repatriation, highlighting concerns about the treatment she has received in US custody. Attorney Naim Haroon Sakhia commented on the lawsuit, stating, “Dr. Siddiqui has endured unimaginable suffering, and this case is a glaring example of the severe issues plaguing the US prison system.” Maria Kari emphasised that the lawsuit seeks justice not just for Siddiqui, but for other women who have suffered in silence. The US Bureau of Prisons has yet to respond to the lawsuit, but the case is likely to have far-reaching implications for prison reform and the treatment of detainees, particularly women, in US facilities. This legal action underscores ongoing concerns over the treatment of foreign nationals in US prisons and has the potential to spark further scrutiny of the country’s human rights practices. Dr. Aafia Siddiqui’s arrest is one of the most controversial and mysterious cases, that began in March 2003, following the arrest of Khalid Sheikh Mohammed (KSM), Al Qaeda’s third-in-command and the alleged mastermind behind the 9/11 attacks, in Karachi. Mohammed was transferred to US custody and sent to Guantanamo Bay, where he was tortured by being subjected to waterboarding and “rectal rehydration” as part of CIA interrogation tactics, according to a Senate report. At the time, Siddiqui, who was reportedly married to a nephew of Khalid Sheikh Mohammed, disappeared along with her three minor children in Karachi. US media described her as the first woman suspected of links to Osama bin Laden’s Al-Qaeda network, earning her the notorious moniker “Lady Al Qaeda.” In 2008, Siddiqui ‘resurfaced’ in Afghanistan, where she was arrested in Ghazni province during a time of intense conflict in Afghanistan. At that point, the Taliban, a resistance militant group, were engaged in fierce battles with Afghan national forces, which were supported by the US-led international coalition. The internal troops in Ghazni included US 1,200 troops, 1600 from Poland and 700 from France. US court documents allege that Siddiqui was found carrying two kilograms of sodium cyanide hidden in bottles of moisturiser, along with plans for attacks on high-profile US targets, including the Brooklyn Bridge and the Empire State Building. Handed over to US forces, Siddiqui reportedly grabbed a rifle during her interrogation and opened fire on American agents, shouting “Death to America” and “I want to kill Americans.” While the agents were unharmed, Siddiqui was shot and wounded in the process. Medical tests conducted in 2008 revealed that Siddiqui had suffered a partial loss of her intestine, raising concerns about her treatment during her years of detention. In 2008, one of her sons was freed in Afghanstan and later shifted to Islamabad. There is no information on how he ended up in Afghanistan. Details about the other two children are not known. In 2010, she was convicted in the Manhattan, US and sentenced to 86 years in prison for attempted murder. However, she was never charged with any direct links to Al Qaeda or terrorism-related activities. Recently during a House Foreign Affairs Committee hearing in 2023, US Congressman Brad Sherman had proposed a potential exchange betweeb Dr. Aafia Siddiqui and Dr. Shakil Afridi, a Pakistani doctor who assisted the CIA in conducting a fake vaccination campaign to locate Al-Qaeda leader Osama bin Laden. In 2012, Afridi was sentenced to 33 years in prison in Pakistan, not for his work with the CIA, but over ties to a banned militant group. His jail time was was later reduced to 10 years. Save my name, email, and website in this browser for the next time I comment. Δ document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() );
Prospera Financial Services Inc lowered its position in shares of Davis Select Financial ETF ( BATS:DFNL – Free Report ) by 2.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 21,837 shares of the company’s stock after selling 520 shares during the period. Prospera Financial Services Inc’s holdings in Davis Select Financial ETF were worth $808,000 as of its most recent filing with the Securities and Exchange Commission (SEC). A number of other hedge funds and other institutional investors have also made changes to their positions in DFNL. Commonwealth Equity Services LLC increased its holdings in Davis Select Financial ETF by 1.9% in the 2nd quarter. Commonwealth Equity Services LLC now owns 61,847 shares of the company’s stock valued at $2,054,000 after purchasing an additional 1,153 shares during the last quarter. Sanctuary Advisors LLC purchased a new position in Davis Select Financial ETF in the 2nd quarter valued at approximately $1,608,000. Arkansas Financial Group Inc. boosted its position in Davis Select Financial ETF by 48.2% in the 3rd quarter. Arkansas Financial Group Inc. now owns 21,511 shares of the company’s stock valued at $796,000 after buying an additional 6,993 shares during the period. Carson Advisory Inc. purchased a new position in Davis Select Financial ETF in the 3rd quarter valued at approximately $213,000. Finally, Benjamin F. Edwards & Company Inc. boosted its position in Davis Select Financial ETF by 327.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,710 shares of the company’s stock valued at $57,000 after buying an additional 1,310 shares during the period. Davis Select Financial ETF Price Performance Shares of DFNL stock opened at $40.67 on Friday. The stock has a market cap of $235.89 million, a PE ratio of 13.22 and a beta of 0.84. The firm has a 50 day simple moving average of $38.01 and a 200 day simple moving average of $35.60. Davis Select Financial ETF Profile The Davis Select Financial ETF (DFNL) is an exchange-traded fund that is based on the S&P 500 Financials index. The fund is an actively-managed portfolio of global financial sector stocks. The fund seeks long-term growth of capital. DFNL was launched on Jan 11, 2017 and is managed by Davis. Featured Articles Want to see what other hedge funds are holding DFNL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davis Select Financial ETF ( BATS:DFNL – Free Report ). Receive News & Ratings for Davis Select Financial ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davis Select Financial ETF and related companies with MarketBeat.com's FREE daily email newsletter .With the news that Cadillac is joining F1 in 2026, Mario Andretti has been named to the board of directors for the organization. An Andretti-Cadillac team was denied entry in 2023, but this new formation is more acceptable to the FIA. Mario Andretti is a legend. Formula One, NASCAR, IndyCar – there isn’t much that he wasn’t able to accomplish during his driving days. At 84 years old, he’s headed back to F1. Today, Andretti responded to the news . He is more than happy to have a role within this new organization. “I feel very lucky that I’ve been able to stick around for this long and do what I love for so long,” the legendary driver wrote on social media. “And the idea that the Cadillac F1 Team wants me around...I’ll help where I can, a non-exclusive role with the team, not involved in day-to-day operations (because I don’t want a job), but offering advice, inspiration, friendship anywhere I can. I am beyond fortunate.” I feel very lucky that I've been able to stick around for this long and do what I love for so long. And the idea that the Cadillac F1 Team wants me around....I'll help where I can, a non-executive role with the team, not involved in day-to-day operations (because I don't want a... This won’t be Andretti Global. However, this appears to be a solid compromise. There are several Andretti allies and close business partners on the Cadillac F1 team. Dan Towriss and Mark Walter will lead the team, they are majority owners at Andretti Global. As for the engines that they will run, Cadillac F1 will use Ferrari engines for 2026 and 2027. They will then introduce their own engine in 2028. Cadillac enters F1, could it come to NASCAR? Cadillac races globally. Their addition to F1 is a big deal. But could Cadillac get involved in NASCAR? With the Chevy Camaro being discontinued, is there a chance that GM could swap Chevy out for the Cadillac brand? To answer those questions simply, I don’t think so. It sounds far-fetched. Cadillac competes in sports car racing, IMSA, WEC, and now F1 – stock car racing doesn’t really fit the brand. But for a certain race fan, a Cadillac brand in the Cup Series would be a dream come true. NASCAR is hoping to add another manufacturer. There are a lot of rumors about Honda and maybe Hyundai. But any additions are likely years away. Could a rebranding from Chevy to Cadillac make NASCAR a more attractive brand for other manufacturers? Again, I’m not sure that’s a legitimate solution, but may be a fun offseason debate. Cadillac F1 team has me thinking about a Next Gen CT5 and I don’t hate the picture in my head. If you could pick any manufacturer to invest into NASCAR, who would you choose? This article first appeared on 5 GOATs and was syndicated with permission.
Did Democrats Run Too Far to the Left?Liverpool drew 3-3 on Tyneside (Owen Humphreys/PA) Fabian Schar snatched victory from Liverpool’s grasp as Newcastle held the Premier League leaders to a rip-roaring 3-3 draw at St James’ Park. Mohamed Salah looked to have rescued an eighth successive win in all competitions when his second-half double – both set up by substitute Trent Alexander-Arnold – put the visitors 3-2 ahead after Alexander Isak and Anthony Gordon had struck either side of Curtis Jones’ equaliser. However, Switzerland defender Schar squeezed home a 90th-minute equaliser to claim a deserved point at the end of a thrilling encounter which rekindled memories of the two 4-3 classics between the sides during the 1990s. We need your consent to load this Social Media content. We use a number of different Social Media outlets to manage extra content that can set cookies on your device and collect data about your activity. The tone was set early on when Caoimhin Kelleher had to palm away Sandro Tonali’s second-minute shot, and they needed skipper Virgil van Dijk’s intervention when he hacked away Isak’s cross inside the six-yard box with Bruno Guimaraes awaiting a tap-in after the striker had exchanged passes with Joelinton. The Reds responded in determined fashion, Alexis Mac Allister sending Nick Pope sprawling to palm away his low drive before clipping the outside of a post with a left-foot attempt after a corner had been half-cleared. Newcastle almost took the lead in spectacular style in the 22nd minute. Gordon muscled Salah off the ball, Isak picked out Jacob Murphy’s run with a fine pass and his shot flew past Kelleher and hit the base of the post. Guimaraes fired straight at the keeper after Isak had tricked his way deep into the box and crossed seconds later, and Lewis Hall was only denied a close-range shot at goal by Joe Gomez’s desperate challenge after Isak had nutmegged Van Dijk and threaded the needle. Alexander Isak scores the opening goal (Owen Humphreys/PA) The deadlock was broken 10 minutes before half-time when Guimaraes slid the ball into the Sweden international’s path and saw him step outside Van Dijk before blasting an unstoppable shot past Kelleher. It should have been 2-0 within three minutes when Gomez’s error gifted Gordon a free run at goal, only for the former Everton winger to stab the ball straight at a grateful Kelleher. Having finished the first half in the ascendancy, the hosts returned determined to maintain their momentum, but it was punctured within five minutes when Salah, who had endured a quiet evening until that point, found time and space on the right to cross for Jones to sweep home an equaliser. Cody Gakpo saw a 53rd-minute effort deflected just wide and Darwin Nunez just failed to get a touch on the Netherlands international’s header back across goal. Mohamed Salah thought he had scored a winner (Owen Humphreys/PA) Gomez threw himself into the path of Gordon’s shot after he had surged deep into enemy territory on the hour, but the Liverpool-born frontman was not to be denied and when Isak accepted Guimaraes’ pass and slid him in, he cut inside before firing across Kelleher to make it 2-1. Pope produced a fine reaction save to keep out Jones’ 65th-minute header, but he was beaten for a second time three minutes later when substitute Alexander-Arnold crossed for Salah to whip the ball inside the far post. Murphy lifted the ball over the advancing Kelleher but wide of the goal after running on to Gordon’s pass over the top, but Salah was denied by the upright after forcing his way in from the right with eight minutes to go. He thought he had won it seconds later when he span on Alexander Arnold’s cross and beat Pope for his 15th goal of the season, only for Schar to snatch a point when he slid in to convert Guimaraes’ free-kick from a tight angle.
